These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9919728)

  • 1. Hepatitis C and the 'cure'.
    Cooksley WG
    Aust Fam Physician; 1998 Dec; 27(12):1086. PubMed ID: 9919728
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis C is curable. Even slightly elevated liver enzymes need further examination].
    Niederau C
    MMW Fortschr Med; 2008 Mar; 150(13):26. PubMed ID: 18522352
    [No Abstract]   [Full Text] [Related]  

  • 3. An economic analysis of antiviral therapy in patients with advanced hepatitis C virus disease: still not there!
    Rubin A; Berenguer M
    Liver Transpl; 2010 Jun; 16(6):697-700. PubMed ID: 20517902
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hepatitis C virus associated extrahepatic manifestations].
    Duclos-Vallée JC
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B76-81. PubMed ID: 12180311
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of acute hepatitis C].
    Fainboim H; García D; Muñoz A
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S48-50. PubMed ID: 20214302
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis C and alcohol].
    Perlemuter G
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indications for combination interferon-ribavirin therapy in chronic hepatitis C].
    Blum HE
    Internist (Berl); 1998 Sep; 39(9):981. PubMed ID: 9788122
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hepatitis C: advances and consensus].
    Lerebours E; Marcellin P; Dhumeaux D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B5-6. PubMed ID: 12180308
    [No Abstract]   [Full Text] [Related]  

  • 9. [International consensus conference on hepatitis C. Conclusions. Organized under the auspices of the European Association for the Study of the Liver (EASL)].
    Ann Med Interne (Paris); 1999 Sep; 150(5):449-53. PubMed ID: 10544760
    [No Abstract]   [Full Text] [Related]  

  • 10. [Future outlook for treatment of chronic hepatitis C: IFN + ribavirin combination therapy].
    Iino S
    Rinsho Byori; 2001 Aug; 49(8):747-54. PubMed ID: 11573281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical guidelines of diagnosis and treatment of hepatitis C].
    Rev Gastroenterol Mex; 2007; 72(2):177-91. PubMed ID: 17966381
    [No Abstract]   [Full Text] [Related]  

  • 12. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
    Jessner W; Der-Petrossian M; Christiansen L; Maier H; Steindl-Munda P; Gangl A; Ferenci P
    Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
    Lucidarme D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon-based therapy of hepatitis C.
    Chevaliez S; Pawlotsky JM
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1222-41. PubMed ID: 17869375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance].
    Pol S
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B264-73. PubMed ID: 12180300
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease.
    Abdelmalek MF; Liu C; Valentine JF
    Am J Gastroenterol; 2007 Jun; 102(6):1333-4. PubMed ID: 17531027
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained response to interferon-ribavirin combination therapy predicted by a model of hepatitis C virus dynamics using both HCV RNA and alanine aminotransferase.
    Colombatto P; Civitano L; Oliveri F; Coco B; Ciccorossi P; Flichman D; Campa M; Bonino F; Brunetto MR
    Antivir Ther; 2003 Dec; 8(6):519-30. PubMed ID: 14760885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapeutic strategies for hepatitis C.
    Di Bisceglie AM; McHutchison J; Rice CM
    Hepatology; 2002 Jan; 35(1):224-31. PubMed ID: 11786980
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of patients with chronic hepatitis C virus infection and normal transaminases].
    Serfaty L
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B202-5. PubMed ID: 12180289
    [No Abstract]   [Full Text] [Related]  

  • 20. [What therapy is meaningful in chronic hepatitis C and resection of hepatocellular carcinoma for recurrence prophylaxis?].
    Malfertheiner P
    Dtsch Med Wochenschr; 2002 Nov; 127(48):2580. PubMed ID: 12457331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.